We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current XENE market cap is 2.69B. The company's latest EPS is USD -2.3829 and P/E is -14.76.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -53.06M | -83.47M | -55.84M | -72.31M | -97.31M |
| Net Income | -48.46M | -44.74M | -47.93M | -57.92M | -62.79M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6.83M | 32.17M | 18.44M | 9.43M | 0 |
| Operating Income | -42.82M | -31.3M | -78.99M | -129.14M | -214.05M |
| Net Income | -41.6M | -28.01M | -77.09M | -124.94M | -182.39M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 671.09M | 964.8M | 919.02M | 884.01M | 835.9M |
| Total Liabilities | 34.5M | 36.88M | 31.33M | 39.96M | 38.09M |
| Total Equity | 636.59M | 927.92M | 887.7M | 844.05M | 797.81M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 147.7M | 189.19M | 572.01M | 754.15M | 964.8M |
| Total Liabilities | 55.72M | 17.83M | 21.97M | 32.65M | 36.88M |
| Total Equity | 91.98M | 171.36M | 550.03M | 721.5M | 927.92M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -109.86M | -145.33M | -43.18M | -75.86M | -127M |
| Investing | 122.56M | -117.17M | -46.2M | 64.52M | 66.5M |
| Financing | 29.51M | 353.52M | N/A | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.63M | -48.12M | -69.5M | -98.43M | -145.33M |
| Investing | -66.29M | -16.82M | -246.77M | -296M | -117.17M |
| Financing | 27.52M | 85.8M | 447.54M | 278.47M | 353.52M |
| Market Cap | 2.69B |
| Price to Earnings Ratio | -14.76 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 18.12 |
| Price to Book Ratio | 2.9 |
| Dividend Yield | - |
| Shares Outstanding | 76.54M |
| Average Volume (1 week) | 502.08k |
| Average Volume (1 Month) | 533.59k |
| 52 Week Change | -20.50% |
| 52 Week High | 46.00 |
| 52 Week Low | 33.27 |
| Spread (Intraday) | 2.87 (7.84%) |
| Company Name | Xenon Pharmaceuticals Inc |
| Address |
200 - 3650 gilmore way burnaby, british columbia V5G 4W8 |
| Website | https://www.xenon-pharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
